Our finding of IGF-1R upregulation in NEVs is promising because several post-mortem and epidemiological studies support the idea that upregulation of IGF signaling may protect against Alzheimer’s disease (AD). This evidence concerns the gene IGF1R and early-onset autosomal dominant Alzheimer disease.